FDA Approves New Oral Obesity Pill Foundayo

The FDA has granted fast-track approval for Foundayo, a new once-daily oral pill from Eli Lilly for weight loss management. This drug enters the market as a direct competitor to Novo Nordisk's injectable Wegovy, offering patients a non-injection alternative. The approval signals a shift in the obesity treatment landscape toward oral medication options.